Swedish Orphan Biovitrum AB (SOBI)
SOBI · Health Care · 
Sweden
Swedish Orphan Biovitrum AB (SOBI) is a Swedish company in the Health Care sector. The stock has its largest weight in XDWH (MSCI World Health Care), at 0.10%. Anyone who holds an ETF containing Swedish Orphan Biovitrum also has an indirect stake in the company.
Data and Charts: Swedish Orphan Biovitrum
Key Data for Swedish Orphan Biovitrum
Alysly Data Analysis: Swedish Orphan Biovitrum
What ETF Is Swedish Orphan Biovitrum In?
Swedish Orphan Biovitrum has very high ETF coverage and is held by 24 of the 104 ETFs we track, which together follow 9 indices. That puts the stock in more ETFs than 90.5% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XDWH | MSCI World Health Care | 0.10% | €0.98 |
| SPFS | MSCI World Health Care | 0.10% | €0.97 |
| EXSA | STOXX Europe 600 | 0.08% | €0.80 |
| X600 / XESU | STOXX Europe 600 | 0.08% | €0.77 |
| XSX6 / XSX7 | STOXX Europe 600 | 0.08% | €0.76 |
| IMEA | MSCI Europe | 0.07% | €0.70 |
| XMEU / XIEE | MSCI Europe | 0.07% | €0.66 |
| SPYE | MSCI Europe | 0.06% | €0.64 |
| EXUS / EXU1 | MSCI World ex USA | 0.04% | €0.37 |
| XDEM | MSCI World Momentum | 0.03% | €0.33 |
| WIMI | MSCI World IMI | 0.01% | €0.14 |
| XDWD / XDWL | MSCI World | 0.01% | €0.11 |
| EUNL | MSCI World | 0.01% | €0.10 |
| IUSQ | MSCI ACWI | 0.01% | €0.10 |
| SPYI / SPSA | MSCI ACWI IMI | 0.01% | €0.07 |
| SWWD | MSCI World | 0.01% | €0.07 |
| SPYY | MSCI ACWI | 0.01% | €0.07 |
| SPPW | MSCI World | 0.01% | €0.07 |
The last column shows how much of €1,000 in one of these funds goes to Swedish Orphan Biovitrum, based on each fund's latest holdings list.
US-listed ETFs holding Swedish Orphan Biovitrum (weight per latest SEC filing): VXUS 0.02%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
Swedish Orphan Biovitrum Weight in iShares STOXX Europe 600 (EXSA) Since 2019
In iShares STOXX Europe 600 (EXSA), Swedish Orphan Biovitrum had a weight of 0.03% on Sep 30, 2019 and 0.08% on Oct 30, 2026. The fund tracks the STOXX Europe 600. Its share peaked at 0.08% on Jun 30, 2026. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Swedish Orphan Biovitrum overlaps with the rest of a portfolio.
Stocks With ETF Exposure Similar to Swedish Orphan Biovitrum
| Stock | Shared ETFs | r |
|---|---|---|
| Swedish Orphan Biovitrum | – | – |
| Sandoz Group Ltd | 24 | – |
 Galderma Group N | 24 | – |
| Demant A/S | 23 | – |
 Haleon | 23 | – |
| Alcon | 23 | – |
| Coloplast A/S | 23 | – |
 Lonza Group | 23 | – |
| Sonova Holding | 23 | – |
These stocks reach a portfolio through largely the same funds as Swedish Orphan Biovitrum. “Shared ETFs” counts the funds that hold both.
